Invasive breast carcinoma - IARC

757. Eichhorn JH, Scully RE (1991). Ovarian
myxoma: clinicopathologic and immunocytologic
analysis of five cases and a review
of the literature. Int J Gynecol Pathol 10:
156-169.
7 5 8 . Eichhorn JH, Scully RE (1995).
"Adenoid cystic" and basaloid carcinomas
of the ovary: evidence for a surface epithelial
lineage. A report of 12 cases. Mod
Pathol 8: 731-740.
7 5 9 . Eichhorn JH, Scully RE (1996).
Endometrioid ciliated-cell tumors of the
ovary: a report of five cases. Int J Gynecol
Pathol 15: 248-256.
760. Eichhorn JH, Young RH, Clement PB,
Scully RE (2002). Mesodermal (mullerian)
adenosarcoma of the ovary: a clinicopathologic
analysis of 40 cases and a
review of the literature. Am J Surg Pathol
26: 1243-1258.
761. Eichhorn JH, Young RH, Scully RE
(1992). Primary ovarian small cell carcinoma
of pulmonary type. A clinicopathologic,
immunohistologic, and flow cytometric
analysis of 11 cases. Am J Surg Pathol 16:
926-938.
762. Eifel P, Hendrickson M, Ross J, Ballon
S, Martinez A, Kempson R (1982).
Simultaneous presentation of carcinoma
involving the ovary and the uterine corpus.
Cancer 50: 163-170.
7 6 3 . Eisen A, Rebbeck TR, Lynch HT,
Lerman C, Ghadirian P, Dube MP (2000).
Reduction in Breast Cancer Risk following
Bilateral Prophylactic Oophorectomy in
BRCA1 and BRCA2 Mutation Carriers. Am
J Hum Genet 67: 58.
764. Eisinger F, Jacquemier J, Charpin C,
Stoppa-Lyonnet D, Bressac-de Paillerets
B, Peyrat JP, Longy M, Guinebretiere JM,
Sauvan R, Noguchi T, Birnbaum D, Sobol H
(1998). Mutations at BRCA1: the medullary
breast carcinoma revisited. Cancer Res 58:
1588-1592.
765. Eisinger F, Jacquemier J,
Guinebretiere JM, Birnbaum D, Sobol H
(1997). p53 involvement in BRCA1-associated
breast cancer. Lancet 350: 1101.
766. Eisinger F, Jacquemier J, Nogues C,
Birnbaum D, Sobol H (1999). Steroid receptors
in hereditary breast carcinomas associated
with BRCA1 or BRCA2 mutations or
unknown susceptibility genes. Cancer 85:
2291-2295.
767. Eisner RF, Nieberg RK, Berek JS
(1989). Synchronous primary neoplasms of
the female reproductive tract. G y n e c o l
Oncol 33: 335-339.
768. Elliott P, Coppleson M, Russell P,
Liouros P, Carter J, MacLeod C, Jones M
(2000). Early invasive (FIGO stage IA) carcinoma
of the cervix: a clinico-pathologic
study of 476 cases. Int J Gynecol Cancer
10: 42-52.
769. Ellis DL, Teitelbaum SL (1974).
Inflammatory carcinoma of the breast. A
pathologic definition. Cancer 33: 1045-1047.
770. Ellis IO, Elston CW, Goulding H, et al.
(1998). Miscellaneous benign lesions. In:
The Breast. CW Elston and IO Ellis (Ed.) 1st
ed. Churchill Livingstone: Edinburgh, p. 224.
771. Ellis IO, Galea M, Broughton N, Locker
A, Blamey RW, Elston CW (1992).
Pathological prognostic factors in breast
cancer. II. Histological type. Relationship
with survival in a large study with longterm
follow-up. Histopathology 20: 479-489.
772. Ellis IO, Galea MH, Locker A, Roebuck
EJ, Elston CW, Blamey RW, Wilson ARM
(1993). Early experience in breast cancer
screening: Emphasis on development of
protocols for triple assessment. Breast 2:
148-153.
773. Elsheikh A, Keramopoulos A, Lazaris
D, Ambela C, Louvrou N, Michalas S (2000).
Breast tumors during adolescence. Eur J
Gynaecol Oncol 21: 408-410.
774. Elston C.W, Ellis I.O. (1998).
Classification of malignant breast disease.
In: The Breast. Systemic Pathology. CW
Elston and IO Ellis (Eds.) 3rd ed. Churchill
Livingstone: Edinburgh, pp. 239-247.
775. Elston C.W, Ellis I.O. (1998).
Fibroadenoma and related conditions. In:
The Breast. CW Elston and IO Ellis (Ed.)
Churchill Livingstone: Edinburgh.
775a. Elston CW, Bagshawe KD (1972). The
diagnosis of trophoblastic tumours from
uterine curettings. J Clin Pathol 25: 111-
118.
776. Elston CW, Bagshawe KD (1972). The
value of histological grading in the management
of hydatidiform mole. J Obstet
Gynaecol Br Commonw 79: 717-724.
777. Elston CW, Ellis IO (1991). Pathological
prognostic factors in breast cancer. I. The
value of histological grade in breast cancer:
experience from a large study with
long-term follow-up. Histopathology 1 9 :
403-410.
778. Elston CW, Ellis IO (1998). Metastases
within the breast. In: The Breast. C W
Elston and IO Ellis (Eds.) Churchill
Livingstone: Edinburgh.
779. Elston CW, Ellis IO (1998). Systemic
pathology 3E. In: The Breast. CW Elston
and IO Ellis (Eds.) Churchill Livingstone:
Edinburgh.
780. Elston CW, Sloane JP, Amendoeira I,
Apostolikas N, Bellocq JP, Bianchi S,
Boecker W, Bussolati G, Coleman D,
Connolly CE, Dervan P, Drijkoningen M,
Eusebi V, Faverly D, Holland R, Jacquemier
J, Lacerda M, Martinez-Penuela J, De
Miguel C, Mossi S, Munt C, Peterse JL,
Rank F, Reiner A, Sylvan M, Wells CA,
Zafrani B (2000). Causes of inconsistency
in diagnosing and classifying intraductal
proliferations of the breast. European
Commission Working Group on Breast
Screening Pathology. Eur J Cancer 3 6 :
1769-1772.
781. Emerich J, Senkus E, Konefka T (1996).
Alveolar rhabdomyosarcoma of the uterine
cervix. Gynecol Oncol 63: 398-403.
782. Emery JD, Kennedy AW, Tubbs RR,
Castellani WJ, Hussein MA (1999).
Plasmacytoma of the ovary: a case report
and literature review. Gynecol Oncol 73:
151-154.
783. Emmert-Buck MR, Chuaqui R, Zhuang
Z, Nogales F, Liotta LA, Merino MJ (1997).
Molecular analysis of synchronous uterine
and ovarian endometrioid tumors. Int J
Gynecol Pathol 16: 143-148.
784. Emoto M, Iwasaki H, Kawarabayashi
T, Egami D, Yoshitake H, Kikuchi M,
Shirakawa K (1994). Primary osteosarcoma
of the uterus: report of a case with
immunohistochemical analysis. G y n e c o l
Oncol 54: 385-388.
785. Eng C (1997). Cowden syndrome. J
Genet Counsel 6: 181-191.
786. Eng C (2000). Will the real Cowden
syndrome please stand up: revised diagnostic
criteria. J Med Genet 37: 828-830.
787. Eng C, Parsons R (1998). Cowden syndrome.
In: The Genetic Basis of Human
Cancer. B Vogelstein, K Kinzler (Eds.) New
York: McGraw-Hill, pp. 519-526.
788. Eng C, Parsons R (2001). Cowden syndrome.
In: Metabolic and Molecular Bases
of Inherited Disease. C Scriver, AL
Beaudet, WS Sly, D Valle (Eds.) 8th ed.
McGraw-Hill: New York , pp. 979-988.
789. Enomoto T, Haba T, Fujita M, Hamada
T, Yoshino K, Nakashima R, Wada H,
Kurachi H, Wakasa K, Sakurai M, Murata
Y, Shroyer KR (1997). Clonal analysis of
high-grade squamous intra-epithelial
lesions of the uterine cervix. Int J Cancer
73: 339-344.
790. Enzinger FM, Shiraki M (1967).
Musculo-aponeurotic fibromatosis of the
shoulder girdle (extra-abdominal
desmoid). Analysis of thirty cases followed
up for ten or more years. Cancer 20: 1131-
1140.
791. Erdreich LS, Asal NR, Hoge AF (1980).
Morphologic types of breast cancer: age,
bilaterality, and family history. South Med
J 73: 28-32.
792. Eriksson ET, Schimmelpenning H,
Aspenblad U, Zetterberg A, Auer GU (1994).
Immunohistochemical expression of the
mutant p53 protein and nuclear DNA content
during the transition from benign to
malignant breast disease. Hum Pathol 25:
1228-1233.
7 9 3 . Erlandson RA, Rosen PP (1982).
Infiltrating myoepithelioma of the breast.
Am J Surg Pathol 6: 785-793.
794. Ernster VL, Barclay J, Kerlikowske K,
Wilkie H, Ballard-Barbash R (2000).
Mortality among women with ductal carcinoma
in situ of the breast in the population-based
surveillance, epidemiology and
end results program. Arch Intern Med 160:
953-958.
795. Escalonilla P, Grilli R, Canamero M,
Soriano ML, Farina MC, Manzarbeitia F,
Sainz R, Matsukura T, Requena L (1999).
Sebaceous carcinoma of the vulva. Am J
Dermatopathol 21: 468-472.
796. Esche C, Kruse R, Lamberti C, Friedl W,
Propping P, Lehmann P, Ruzicka T (1997).
Muir-Torre syndrome: clinical features and
molecular genetic analysis. Br J Dermatol
136: 913-917.
797. Essary LR, Kaarami M, Page DL, Wick
MR (1999). Immunohistology of variant
adenosis & pseudoinvasive epithelial proliferations
of the breast: helpful or not? Lab
Invest 79.
798. Esteban JM, Allen WM, Schaerf RH
(1999). Benign metastasizing leiomyoma of
the uterus: histologic and immunohistochemical
characterization of primary and
metastatic lesions. Arch Pathol Lab Med
123: 960-962.
799. Esteller M, Levine R, Baylin SB,
Ellenson LH, Herman JG (1998). MLH1 promoter
hypermethylation is associated with
the microsatellite instability phenotype in
sporadic endometrial carcinomas.
Oncogene 17: 2413-2417.
800. Etzell JE, Devries S, Chew K, Florendo
C, Molinaro A, Ljung BM, Waldman FM
(2001). Loss of chromosome 16q in lobular
carcinoma in situ. Hum Pathol 32: 292-296.
801. Eusebi V, Azzopardi JG (1980). Lobular
endocrine neoplasia in fibroadenoma of
the breast. Histopathology 4: 413-428.
802. Eusebi V, Betts CM, Haagensen DE,
Gugliotta P, Bussolati G, Azzopardi JG
(1984). Apocrine differentiation in lobular
carcinoma of the breast. Hum Pathol 15:
134-140.
803. Eusebi V, Casadei GP, Bussolati G,
Azzopardi JG (1986). Adenomyoepithelioma
of the breast with a distinctive type
of apocrine adenosis. Histopathology 11:
305-315.
804. Eusebi V, Damiani S, Losi L., Millis RR
(1997). Apocrine differentiation in breast
epithelium. Advances Anat Pathol 4: 139-155.
805. Eusebi V, Damiani S, Losi L, Millis RR
(1997). Apocrine differentiation in breast
e p i t h e l i u m . Advances in Anatomic
Pathology 4: 139-155.
806. Eusebi V, Foschini MP, Bussolati G,
Rosen PP (1995). Myoblastomatoid (histiocytoid)
carcinoma of the breast. A type of
apocrine carcinoma. Am J Surg Pathol 19:
553-562.
807. Eusebi V, Lamovec J, Cattani MG,
Fedeli F, Millis RR (1986). Acantholytic variant
of squamous-cell carcinoma of the
breast. Am J Surg Pathol 10: 855-861.
808. Eusebi V, Magalhaes F, Azzopardi AG
(1992). Pleomorphic lobular carcinoma of
the breast: an aggressive tumour showing
apocrine differentiation. Hum Pathol 23:
655-662.
809. Eusebi V, Millis RR, Cattani MG,
Bussolati G, Azzopardi JG (1986). Apocrine
carcinoma of the breast. A morphologic
and immunocytochemical study. Am J
Pathol 123: 532-541.
810. Evans AJ, Pinder SE, Ellis IO, Wilson
AR (2001). Screen detected ductal carcinoma
in situ (DCIS): overdiagnosis or an obligate
precursor of invasive disease? J Med
Screen 8: 149-151. 811. Evans HL (1982).
Endometrial stromal sarcoma and poorly
differentiated endometrial sarcoma.
Cancer 50: 2170-2182.
812. Evans HL, Chawla SP, Simpson C, Finn
KP (1988). Smooth muscle neoplasms of
the uterus other than ordinary leiomyoma.
A study of 46 cases, with emphasis on
diagnostic criteria and prognostic factors.
Cancer 62: 2239-2247.
813. Evans MJ, Langlois NE, Kitchener HC,
Miller ID (1995). Is there an association
between long-term tamoxifen treatment
and the development of carcinosarcoma
(malignant mixed Mullerian tumor) of the
uterus? Int J Gynecol Cancer 5: 310-313.
814. Ewertz M, Holmberg L, Karjalainen S,
Tretli S, Adami HO (1989). Incidence of
male breast cancer in Scandinavia, 1943-
1982. Int J Cancer 43: 27-31.
815. Ewertz M, Holmberg L, Tretli S,
Pedersen BV, Kristensen A (2001). Risk
factors for male breast cancer - a casecontrol
study from Scandinavia. A c t a
Oncol 40: 467-471.
816. Fackenthal JD, Cartegni L, Krainer AR,
Olopade OI (2002). BRCA2 T2722R is a deleterious
allele that causes exon skipping.
Am J Hum Genet 71: 625-631.
817. Fackenthal JD, Marsh DJ, Richardson
AL, Cummings SA, Eng C, Robinson BG,
Olopade OI (2001). Male breast cancer in
Cowden syndrome patients with germline
PTEN mutations. J Med Genet 38: 159-164.
818. Fagundes H, Perez CA, Grigsby PW,
Lockett MA (1992). Distant metastases
after irradiation alone in carcinoma of the
uterine cervix. Int J Radiat Oncol Biol Phys
24: 197-204.
819. Fairfield KM, Hankinson SE, Rosner
BA, Hunter DJ, Colditz GA, Willett WC
(2001). Risk of ovarian carcinoma and consumption
of vitamins A, C, and E and specific
carotenoids: a prospective analysis.
Cancer 92: 2318-2326.
384 References